![logo](/logos/CERS.webp)
Cerus Corporation
NASDAQ:CERS
2.02 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Cerus Corporation |
Symbool | CERS |
Munteenheid | USD |
Prijs | 2.02 |
Beurswaarde | 374,299,940 |
Dividendpercentage | 0% |
52-weken bereik | 1.21 - 2.59 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. William M. Greenman |
Website | https://www.cerus.com |
An error occurred while fetching data.
Over Cerus Corporation
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)